Error: Could not add to watchlist. X
+ Watchlist

Horizon Therapeutics LLC

HPTX:US
Acquired
HPTX:US was acquired by HZNP:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.85
Market Cap (USD)
-
Shares Outstanding (m)
20.977
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.24%
% Price Change
+0.05%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Horizon Therapeutics, LLC operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.
Address
2000 Sierra Point Parkway
Suite 400
Brisbane, CA 94005
United States
Phone
1-650-745-7802
Show More